Page 209 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

170 MÉDICAMENTS EN RELA DON AVEC DES SYSTÈMES HORMONA UX

STEINER K.E. et LIEN E., Hypoglycaemic agents which do not release insulin. Prog.
Med. Chem., 1987, 34, 209-248.
COLCA J.R. et MORTON D.R., Antihyperglycaemic thiazolidinediones : ciglitazone
and its analogues, in : New antidiabetic drugs (BAILEY C.J. &. FLATT P. R edit.)
Smith-Gordon, London, 1990, 258-260.
Pioglitazone hydrochloride, Drugs ofthe Future,1990, 15, 1080-1084.
CS 045, Drugs ofthe Future, 1989,14, 846-848 & 1991,16, 853-854
ZASK A., MAC CALEB M.L., AY 31 637, Drugs of the Future, 1991,16, 505-506.
CLARK D.A., STEVENSON R.W. et URBAN F.J., Englitazone sodium, Drugs of the
Future, 1992,17, 182-184.
Englitazone sodium, CP 72467-2, CP 68722 (racémique) Drugs ofthe future, 1992,17,
182-184 et1993, 18, 267-268.
DOW R. L, BECHLE B.M., CHOU T.T., CLARK D.A., HULIN B. et STEVENSON R.W.
Benzyloxazolidine-2,4-diones as potent hypoglycémie agents. J. Med. Chem.,
1991,34, 1538-1544.
ELLINGBOE J.W., ALESSI T.R., DOLAK T.M., NGUYEN T.T., TOMER J.D., GUZZO F,
BAGLI J.F. et MaC CALEB M., Antihyperglycemic activity of novel substitued 3H-
1,2,3,5-oxathiadiazole, J. Med. Chem., 1992, 35, 1176-1183.
KEES K.L. Benzyloxazolidine-2,4-diones as potent hypoglycémie agent. Chemtracts -
Organic Chemistry, 1992, 5, 181-187.
BUCHHOLZ R.A., LEFKER B.A. et RAVI KIRON M.A., Hypertension therapy : what
next Annual Reports in Médicinal Chemistry, 1993, 28, 69-78.

Dérivés perfluorés
KEES K. L, CHEESEMAN R.S., PROZIALECK D.H. & STEINER K.E. Perfluoro-A/-[4-
(1H-tetrazol-5ylmethyl)phenyl]-alkanamides. A new class of oral antidiabetic
agents. J. Med. Chem.,1989, 32, 11-16.
STEINER K.E., Mac CALEB M.L. et KEES K.L., Perfluroanilides : new tools for the
study of insulin-resistant States in : New antidiabetic drugs (BAILEY C.J. &. FLATT
P. R edit.), Smith-Gordon, London, 1990, 237-244.
KEES K. L, SMITH T.M., MaC CALEB M. L, PROZIALECK D.H., CHEESEMAN R.S.,
CHRISTOS T.E., PATT W.C. et STEINER K.E., Perfluorocarbon-based antidiabetic
agents, J. Med. Chem., 1992, 35, 944-953.
Phénacylimidazolium
DOMINIANNI S.M. et YEN T.T., Oral hypoglycémie agents. Discovery and structure-
activity relationships of phenylacylimidazolium halides, J. Med. Chem., 1989, 32,
2301-2306.
YEN T.T., DOMINIANNI S.J., HARRIS R.A. et STEPHENS T.W., Antihyperglicaemic
phénacylimidazolium compounds stabilize hepatic glycogen. in : New antidiabetic
drugs (BAILEY C.J. &. FLATT P. R edit.), Smith-Gordon, London, 1990, 245-247.
Monosaccharides à fonction biguanide
REITZ A.B., TUMAN R.W., MARCHIONE C.S., JORDAN JR A.D., BOWDEN C.R. &
MARIANOFF B.E., Carbohydrates biguanides as potential hypoglycémie agents.
J. Med. Chem., 1989, 32, 2110-2116.